Abeona Therapeutics Inc. (ABEO)
NASDAQ: ABEO · Real-Time Price · USD
5.12
+0.08 (1.59%)
At close: Feb 18, 2026, 4:00 PM EST
5.06
-0.06 (-1.17%)
After-hours: Feb 18, 2026, 6:25 PM EST

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 2018FY 2017FY 2016FY 2015
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '18 Dec '17 Dec '16 Dec '15
Gene and Cell Therapies
3.50M
Gene and Cell Therapies Growth
147.52%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 2018FY 2017FY 2016FY 2015
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '18 Dec '17 Dec '16 Dec '15
United States
3.50M
United States Growth
147.52%